encyclopedia jump navigation jump search hiv/aids
use hiv/aids disambiguation
hiv/aids name hiv/aids hiv/aids ribbon shape bow ribbon symbol solidarity people live hiv/aids disease symptom illness lymph node fever weight loss complication infection duration cause immunodeficiency virus hiv risk factor exposure blood breast milk sex method blood test prevention sex needle exchange male circumcision pre-exposure prophylaxis prophylaxis treatment therapy life expectancy treatment year life expectancy treatment frequency case live hiv death
immunodeficiency virus infection deficiency syndrome hiv/aids spectrum condition infection immunodeficiency virus hiv infection person symptom period illness period symptom infection system risk infection tuberculosis infection tumor people system symptom infection immunodeficiency syndrome hiv/aids stage weight loss
hiv sex sex blood transfusion needle mother child pregnancy delivery breastfeed fluid saliva tear hiv method prevention sex needle exchange program prophylaxis circumcision disease baby mother child medication cure vaccine treatment course disease life expectancy treatment diagnosis treatment survival time infection year
2016 people hiv death hiv case 2016 africa time hiv/aids disease death hiv/aids disease outbreak area hiv west-central africa century hiv/aids united states center disease control prevention cdc cause hiv/aids part decade
hiv/aids impact society illness source discrimination disease impact misconception hiv/aids belief contact disease subject controversy religion catholic position condom use prevention attention fund filewikipedia-videowiki-hiv- hiv/aids media video summary script content
sign symptom infection latency immunodeficiency syndrome transmission body fluid diagnosis hiv test prevention contact vaccination treatment therapy opportunistic infection diet medicine epidemiology history discovery origin society culture impact religion hiv/aids media portrayal transmission research reference link
sign symptom article sign symptom hiv/aids
stage hiv/aids infection latency hiv/aids infection diagram torso symptom hiv/aids symptom hiv/aids
period contraction hiv hiv hiv syndrome individual illness illness week exposure symptom symptom 4090 case fever lymph node throat inflammation headache tiredness sore mouth genital rash case trunk people infection stage symptom vomit symptom neuropathy syndrome duration symptom week
character symptom sign hiv/aids
case family doctor hospital disease symptom
hiv people fever risk factor infection latency
symptom stage latency hiv hiv treatment second stage history hiv/aids year year average year symptom end stage people experience fever weight loss problem muscle pain people lymphadenopathy enlargement group lymph node groin month
hiv-1 individual load absence treatment hiv/aids proportion level cell helper cell therapy year individual hiv controller nonprogressor group load treatment elite controller elite
person immunodeficiency syndrome diagram torso symptom hiv/aids symptom hiv/aids
immunodeficiency syndrome hiv/aids term t cell count cell l occurrence disease association hiv/aids absence treatment people hiv hiv/aids year condition presence hiv/aids pneumonia form hiv wast syndrome candidiasis sign tract infection
infection bacteria viruse fungy parasite system infection organism person environment infection organ system
people hiv/aids risk viral-induce cancer sarcoma lymphoma system lymphoma cancer sarcoma cancer people hiv second cancer lymphoma cause death people hiv/aids sign hiv/aids cancer herpesvirus cancer hiv/aids association papillomavirus hpv conjunctival cancer layer part eyelid part eye hiv
people hiv/aids symptom fever sweat night lymph node weakness weight loss diarrhea symptom present people hiv/aids symptom infection cancer transmission average act risk hiv exposure route source exposure route chance infection blood transfusion verification childbirth child injection drug use needle stick intercourse intercourse intercourse intercourse intercourse intercourse condom use source intercourse man
hiv route contact exposure body fluid tissue mother child pregnancy delivery breastfeed transmission risk hiv secretion saliva sputum sweat tear urine vomit blood strain condition hiv
mode transmission hiv contact person person load result treatment risk hiv mode hiv transmission contact people sex pattern transmission country
hiv transmission united states men sex men hiv diagnose male diagnose men hiv diagnose men age group diagnose men men hiv women test
regard contact estimate risk hiv transmission act time country country country risk transmission 038 act transmission 030 act estimate country act transmission 008 act transmission risk transmission intercourse 1417 act contact risk transmission sex risk sex case risk 0004 intercourse set prostitution income country risk transmission act transmission 005 act
risk transmission increase presence infection ulcer ulcer risk infection chlamydia vaginosis increase risk transmission
load person risk factor transmission month hiv/aids person time load hiv person stage infection rate transmission
sex worker pornography likelihood hiv sex factor risk transmission assault risk hiv transmission condom trauma vagina rectum risk infection body fluid poster man towel hand word drug life cdc poster threat hiv/aids drug use
second mode hiv transmission blood blood product transmission needle-share drug use needle stick injury transfusion blood blood product injection equipment
risk needle drug injection 063 act average risk hiv needle stick person act risk mucous membrane exposure blood 009 act united states drug user case hiv 2009 area people drug hiv
hiv blood transfusion blood country risk hiv blood transfusion donor selection hiv screen example uk risk united states income country transfusion 2008 hiv/aids area transfusion blood blood product infection screen hiv organ tissue transplantation
injection role hiv spread africa
infection region syringe use world health organization risk transmission result injection africa risk procedure delivery care area world
people tattoo risk infection case mosquitoe insect hiv article hiv pregnancy hiv breastfeed
hiv mother child pregnancy delivery breast milk baby hiv way hiv absence treatment risk transmission birth transmission case hiv children treatment risk infection treatment mother pregnancy delivery caesarean section breastfeed drug antiretroviral mother infant decrease risk transmission measure world blood contaminate food pre-chew risk transmission
woman year breastfeed result hiv/aids risk baby
treatment risk year
risk death breastfeed area world world health organization mother baby medication breastfeed provision formula infection hiv pregnancy miscarriage article hiv diagram viron structure diagram hiv virion structure round object object
scan electron micrograph hiv-1 bude lymphocyte
hiv cause spectrum disease hiv/aids
hiv retrovirus component system cell macrophage cell
hiv member genus part family share characteristics
specy mammal lentiviruse illness incubation period positive-sense rna viruse
entry target cell rna genome reverse dna reverse transcriptase genome virus particle
dna cell nucleus dna integrase host virus virus host cell detection system virus rna genome protein cell virus particle replication cycle
hiv cell route spread spread spread mechanism spread virus particle bud t cell fluid t cell chance encounter hiv transmission cell process spread spread mechanism hiv replication therapy
type hiv hiv-1 hiv-2
hiv-1 virus lav htlv-iiy
cause majority hiv/aids
infectivity hiv-2 hiv-1 people hiv-2 exposure
capacity transmission hiv-2 west africa article pathophysiology hiv/aids hiv/aids waywebmplay media hiv/aids way hiv replication cycle
virus body period replication abundance virus blood
infection level hiv virus particle milliliter blood response drop number cell
viremia activation cell cell antibody production seroconversion
t cell response virus level peak decline t cell count
t cell response disease progression prognosis virus
hiv cause hiv/aids cell
system infection
cell response body fight infection cell
mechanism cell depletion phase phase cell lysis kill cell cell account t cell depletion apoptosis factor
phase consequence activation loss ability system t cell account decline t cell number
symptom deficiency characteristic hiv/aids year person bulk cell loss week infection mucosa majority lymphocyte body reason loss cell majority cell protein hiv co-receptor access cell fraction cell bloodstream change protein chromosome hiv-1 infection
hiv cell infection response infection phase
cell tissue hiv replication state activation phase activation activation state cell release cytokine result activity hiv gene product response hiv replication
breakdown surveillance system barrier depletion cell phase disease diagnosis article diagnosis hiv/aids graph line
move right left rise middle
line move zero graph relationship hiv copy load t cell count course hiv/aids
hiv rna copy ml plasma day exposure test blood test day antibody test test elisa gen antibody antigen test elisa gen pcr
hiv/aids laboratory test presence sign symptom hiv screen united states service task force people year year age women test risk illness area world hiv carrier stage disease hiv/aids immunodeficiency hiv test
people hiv antibody week infection diagnosis hiv seroconversion hiv-rna antigen result antibody pcr test antibody pcr
antibody test children month due presence antibody hiv/aids pcr test hiv rna dna test antigen world access pcr test place symptom child antibody test africa 20072009 population hiv status 2009 men women country increase year
stage system hiv disease surveillance purpose disease stage system hiv/aids disease cdc classification system hiv/aids classification system country
stage system laboratory test condition country guide management
difference system comparison purpose
world health organization definition hiv/aids classification time version system category
hiv/aids syndrome stage hiv/aids t cell count count l mm blood lymph node enlargement stage symptom mucocutaneous manifestation tract infection
count stage symptom diarrhea month infection tuberculosis lung count stage hiv/aids symptom toxoplasmosis brain candidiasis trachea bronchy lung sarcoma
united states center disease control prevention classification system hiv 2008 system hiv/aids count symptom infection group year age
stage time hiv test day test
stage count
hiv/aids condition
stage count hiv/aids condition
stage count
hiv/aids condition
information classification
surveillance purpose hiv/aids diagnosis treatment t cell count rise blood hiv/aids illness prevention article prevention hiv/aids run build number sign hiv/aids prevention hiv/aids clinic mcleod ganj pradesh india contact
condom use risk hiv transmission term condom couple person rate hiv/aids year evidence condom level protection application gel transcriptase inhibitor sex infection rate women contrast use spermicide nonoxynol-9 risk transmission tendency irritation
africa acquisition hiv men month study world health organization un hiv/aids circumcision method hiv transmission area rate hiv transmission benefit country men sex men antiviral society male option men sex men expert perception vulnerability men risk-take behavior effect
program abstinence hiv risk evidence benefit peer education education school risk behavior minority people practice hiv/aids risk hiv counsel test people hiv behavior condom use infection hiv pre-exposure
treatment people hiv count
cellsl way hiv/aids partner strategy treatment prevention tasp fold reduction transmission risk prophylaxis dose medication emtricitabine people risk men sex men couple hiv heterosexual africa drug user study decrease risk person year uspstf draft risk
precaution health care environment risk hiv drug use risk factor harm reduction strategy program substitution therapy risk
course antiretroviral hour exposure blood secretion prophylaxis pep use agent zidovudine risk hiv/aids injury prevention regimen united states medicationstenofovir risk
pep treatment assault perpetrator hiv hiv status duration treatment week zidovudine case result effect nausea fatigue distress headache article hiv pregnancy
program transmission hiv mother children rate transmission use combination medication pregnancy birth infant bottle breastfeed replacement feed mother infant breastfeed month life case breastfeed provision antiretroviral prophylaxis infant risk transmission cuba country world transmission hiv vaccination article hiv vaccine
vaccine hiv hiv/aids vaccine trial date 2009 reduction risk transmission hope research community vaccine trial vaccine treatment article management hiv/aids
cure hiv vaccine
treatment antiretroviral therapy progression disease people income country treatment treatment infection
therapy prescription bottle label
pill mark side gsy
once-daily art regime emtricitabine booster
haart option combination cocktail medication type class agent treatment reverse transcriptase inhibitor nucleoside transcriptase inhibitor nrtis zidovudine azt tenofovir 3tc ftc combination agent protease inhibitor pi regimen effectiveness
world health organization united states people age women diagnosis count treatment break holiday people treatment outcome treatment term plasma count copiesml level treatment week level check month control copiesml criteria treatment people year
benefit treatment risk progression hiv/aids risk death world treatment health treatment risk tuberculosis benefit risk transmission disease partner decrease transmission effectiveness treatment part compliance reason non-adherence access care support illness drug abuse complexity treatment regimen pill number dose frequency effect adherence cost issue medication income country rate adherence country
event agent event syndrome diabete mellitus protease inhibitor symptom risk disease treatment effect medication birth defect women children
treatment recommendation children adult
world health organization children year age children adult united states guideline children month age hiv rna copiesml year year age infection
measure infection people hiv/aids
addition disease treatment antiretroviral risk infection adult adolescent hiv therapy evidence tuberculosis set tuberculosis burden therapy skin test vaccination hepatitis people risk hiv infection prophylaxis week age breastfeed infant hiv mother resource set pcp person count cellsul pcp people immunosuppression therapy toxoplasmosis mac measure rate infection vaccination vaccine people hiv/aids evidence benefit diet article nutrition hiv/aids
world health organization recommendation nutrient requirement hiv/aids diet
intake micronutrient level adult intake vitamin zinc iron effect hiv adult deficiency supplementation people hiv nutrition deficiency system infection evidence benefit morbidity reduction mortality
evidence supplementation selenium evidence benefit women hiv supplement outcome mother children mother medication hiv transmission multivitamin supplement treatment evidence vitamin supplementation children hiv/aids mortality growth medicine
people hiv use form medicine effectiveness therapy evidence use medicine evidence use cannabis increase appetite weight gain death hiv/aids person 2012 3561 4591402
hiv/aids disease area world prognosis people count load outcome treatment average survival time infection hiv year hiv subtype diagnosis hiv/aids treatment survival range month prevention infection death rate life expectancy adult year population treatment infection prognosis example treatment diagnosis hiv/aids life expectancy year infant hiv year age treatment map world saharan africa disability-adjust life year hiv hiv/aids inhabitant
5001000 50007500
cause death hiv/aids infection cancer result failure system risk cancer count
l rate disease progression individual number factor person susceptibility function access health care presence co-infection strain strain virus
tuberculosis co-infection cause sickness death hiv/aids present people death hiv risk factor tuberculosis hepatitis disease progression cancer hiv/aids sarcoma hiv/aids lymphoma cancer cancer lymphoma system lymphoma cancer
treatment term people disorder osteoporosis neuropathy cancer nephropathy disease condition hiv treatment epidemiology article epidemiology hiv/aids map world land saharan africa percentage hiv adult country data
hiv/aids people hiv number infection year infection population women children death peak
sub-saharan africa region
hiv case death region adult population cause death children contrast region women case south africa population people hiv country world life expectancy country hiv/aids example year botswana transmission 2013 botswana south africa improvement nation access therapy
south south east asia second region case people hiv death case india
2008 united states people hiv death
center disease control prevention american infection 2016 people hiv/aids begine hiv epidemic kingdom case death canada 2008 case death recognition hiv/aids death prevalence east north africa east asia europe country 2009 2012 estimate russia ukraine latvia moldova portugal belarus order prevalence history article history hiv/aids discovery text morbidity mortality report newsletter morbidity mortality report hiv/aids
hiv/aids june case united states case cluster drug user men cause immunity symptom pneumocystis cariniy pneumonia pcp infection people system number men skin cancer sarcoma ks case pcp ks
center disease control prevention cdc cdc task force outbreak
day cdc name disease way disease example lymphadenopathy disease discoverer hiv virus sarcoma infection name task force point cdc phrase disease syndrome heroin user homosexual haitian press term grid deficiency hiv/aids community term grid term hiv/aids meet july september cdc disease hiv/aids
research group robert luc montagnier novel retrovirus people hiv/aids find issue journal science virus group person hiv/aids shape t-lymphotropic viruse group
group virus
time group virus person swell lymph node neck weakness characteristic symptom hiv/aids
report group colleague core protein virus
group virus virus viruse hiv origin primate source hiv left right monkey source siv mangabey source hiv-2 chimpanzee source hiv-1
hiv-1 primate west-central africa human century hiv-1 cameroon evolution sivcpz immunodeficiency virus chimpanzee hiv-1 chimpanzee subspecy pan troglodytes relative hiv-2 virus mangabey aty world monkey live west africa senegal cte world monkey owl monkey hiv-1 infection fusion resistance gene hiv-1 specy barrier occasion rise group virus m n o
evidence human activity hunter vendor virus system week infection
transmission virus individual individual succession time hiv transmission rate population presence transmission channel africa century
transmission channel virus human spread society time cross
study virus ancestor hiv-1 m group proponent date link hiv epidemic emergence colonialism growth city change degree promiscuity spread prostitution frequency ulcer disease syphilis city transmission rate hiv intercourse circumstance fold partner infection ulcer
city prevalence prostitution ulcer degree resident kinshasa prostitute resident city syphilis
view practice africa world war reuse use syringe vaccination antibiotic treatment campaign vector virus human spread
case hiv date congo case hiv/aids norway begine july wake independence nation expert technician world gap belgium elite country
haitian group expert group total country dr
jacques author origin hiv/aids haiti entry point united states hiv atlantic virus united states majority infection africa individual hiv haiti infection united states time epidemic group men sex men
prevalence hiv-1 resident new york city san francisco individual country society culture article discrimination people hiv/aids male hand rest shoulder camera ryan white poster child hiv school
hiv/aids stigma world variety way ostracism rejection discrimination avoidance hiv people hiv test consent protection confidentiality violence hiv individual people hiv quarantine hiv individual violence fear violence people hiv test result treatment illness death sentence spread hiv
hiv/aids stigma category
hiv/aids reflection fear apprehension illness hiv/aids use hiv/aids attitude group lifestyle disease courtesy hiv/aids people issue hiv/aids people
hiv/aids stigma conjunction homosexuality bisexuality promiscuity prostitution drug use
country association hiv/aids homosexuality bisexuality association level prejudice attitude association hiv/aids behavior sex men mode spread hiv transmission
part reform marriage population legislation people hiv/aids china
library medicine exhibition hiv/aids politics culture research government response story people hiv/aids caregiver activist impact article impact hiv/aids cost hiv treatment graph number line fall line mid-1980 change life expectancy country
hiv/aids economics individual country product country lack capital nutrition health care medicine number people hiv/aids complication
hiv/aids orphan grandparent
work begine treatment hiv/aids people worker
unemployment people hiv/aids memory problem isolation
employment self-esteem sense dignity confidence quality life people hiv/aids
treatment people hiv/aids work chance person hiv/aids quality evidence
adult hiv/aids population turn resource expenditure education health service hiv/aids pressure state finance growth economy
growth tax base effect expenditure train worker pay care hiv/aids orphan
increase adult mortality responsibility blame family government care orphan
household level hiv/aids loss income spend healthcare
study divoire household person hiv/aids expense household
expenditure income education family investment religion hiv/aids article religion hiv/aids
topic religion hiv/aids year authority opposition use condom approach spread hiv/aids report health expert matthew hanley church hiv/aids crisis change re-emphasis fidelity marriage abstinence outside
organization prayer hiv/aids
bbc churche london prayer hiv/aids centre study health hiv people medication advice pastor number death synagogue church nation anoint water god group people medication media portrayal article media portrayal hiv/aids
case hiv/aids rock hudson actor life october virus july year
casualty hiv/aids year nicholas eden politician son minister anthony eden november virus life rock star freddie mercury lead singer band queen hiv/aids illness diagnosis day hiv case virus arthur ashe tennis player
hiv august virus blood transfusion heart surgery
test hour diagnosis ashe hiv/aids public diagnosis april result february age
therese photograph activist david kirby hiv/aids family april
life magazine photo image hiv/aids epidemic
photo life magazine winner world press photo notoriety color benetton advertise campaign johnson canadian hiv sex women diagnosis
hiv complication hiv/aids aziga murder life transmission article transmission hiv
transmission hiv infection person immunodeficiency virus hiv
country jurisdiction area united states law hiv transmission exposure law hiv
article hiv/aids discredit hiv/aids origin theory
misconception hiv hiv/aids
hiv/aids contact intercourse virgin hiv/aids hiv men drug user
public hiv kiss glass spit toilet seat cough sneez misconception act intercourse men hiv/aids discussion hiv homosexuality school rate hiv/aids
group individual connection hiv hiv/aids existence hiv validity hiv test treatment method claim hiv/aids denialism community impact south africa government embrace hiv/aids 19992005 response country hiv/aids epidemic death hiv/aids
conspiracy theory hiv scientist
operation infektion measure operation claim united states hiv/aids
survey number people claim research article hiv/aids research
hiv/aids research research treat cure hiv/aids research nature hiv agent hiv/aids disease hiv
government research institution hiv/aids research
research health intervention sex education drug development research microbicide disease hiv vaccine drug
research area topics pre-exposure prophylaxis prophylaxis circumcision hiv
health official researcher program picture barrier efficacy approache hiv treatment prevention standard hiv indicator use indicator focus development organization researcher
